Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-01-02 @ 8:20 AM
Study NCT ID:
NCT06869551
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2025-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2030-03-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-03-04
Completion Date Type:
ESTIMATED
First Submit Date:
2025-03-06
First Submit QC Date:
None
Study First Post Date:
2025-03-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-16
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED